KT-056

N/A

Report date: 2023/02/24 17:46:13

Base Information

Drug NameKT-056
Drug Alias NameKT-056
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy
Mechanisms of ActionT lymphocyte replacements
TargetsUpdating
Therapy Area/IndicationsOvarian NeoplasmsNeuroblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesNanjing Kati Medical Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNanjing Kati Medical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsOvarian NeoplasmsNeuroblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A